Concomitant anti–tumor necrosis factor and anti–interleukin 17 therapy in severe, refractory hidradenitis suppurativa: A case series. Bastian et al.
Published: 18 September 2026| Version 1 | DOI: 10.17632/r69bks7brn.1
Contributor:
Estella BastianDescription
Supplemental Figure 1. Change in patient HS-Physician Global Assessment (HS-PGA) scores from baseline to end point. HS-PGA scores were determined at baseline and end point visits. All 10 patients exhibited a decrease in HS-PGA score (P = .002).
Files
Institutions
- Case Western Reserve UniversityOhio, Cleveland
- University of California, San FranciscoCalifornia, San Francisco
Categories
Biologic Therapy, Hidradenitis Suppurativa